Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Perfetto

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|July 9, 1998
FDA reform: implications for health economic research and pharmacy practiceE M Perfetto
The Annals of Pharmacotherapy|October 1, 1996
Agency for Health Care Policy and Research clinical practice guidelinesE M Perfetto, L S Morris
Managed Care Interface|March 7, 2001
Workplace costs associated with acute exacerbation of chronic bronchitis: a comparison of moxifloxacin and levofloxacinJ Li-McLeod, E M Perfetto
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|January 1, 1996
What are outcomes?C D Mullins, R Baldwin, E M Perfetto
Medical Care|April 1, 1995
Public policy and the application of outcomes assessments: paradigms versus politicsK L Benjamin, E M Perfetto, R J Greene
Clinical Therapeutics|December 1, 2001
Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitisE M Perfetto, C D Mullins, P Subedi, et al.
The Annals of Pharmacotherapy|July 1, 1993
Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarctionD C McLeod, W G Coln, C F Thayer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|July 9, 1998
FDA reform: implications for health economic research and pharmacy practiceE M Perfetto
The Annals of Pharmacotherapy|October 1, 1996
Agency for Health Care Policy and Research clinical practice guidelinesE M Perfetto, L S Morris
Managed Care Interface|March 7, 2001
Workplace costs associated with acute exacerbation of chronic bronchitis: a comparison of moxifloxacin and levofloxacinJ Li-McLeod, E M Perfetto
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|January 1, 1996
What are outcomes?C D Mullins, R Baldwin, E M Perfetto
Medical Care|April 1, 1995
Public policy and the application of outcomes assessments: paradigms versus politicsK L Benjamin, E M Perfetto, R J Greene
Clinical Therapeutics|December 1, 2001
Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitisE M Perfetto, C D Mullins, P Subedi, et al.
The Annals of Pharmacotherapy|July 1, 1993
Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarctionD C McLeod, W G Coln, C F Thayer, et al.
Pageof 1